162
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Osteogenic Circulating Endothelial Progenitor Cells are Associated with Vascular Aging of the Large Arteries in Rheumatoid Arthritis

, ORCID Icon, , , , , , , , & show all
Pages 287-294 | Published online: 17 Mar 2022

References

  • Shantsila E, Watson T, Lip GY. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol. 2007;49(7):741–752. doi:10.1016/j.jacc.2006.09.050
  • Chan YH, Ngai MC, Chen Y, et al. Osteogenic circulating endothelial progenitor cells are linked to electrocardiographic conduction abnormalities in rheumatic patients. Ann Noninvasive Electrocardiol. 2019;24(5):e12651. doi:10.1111/anec.12651
  • Gossl M, Modder UI, Atkinson EJ, Lerman A, Khosla S. Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol. 2008;52(16):1314–1325. doi:10.1016/j.jacc.2008.07.019
  • Flammer AJ, Gossl M, Widmer RJ, et al. Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis. Eur Heart J. 2012;33(23):2963–2969. doi:10.1093/eurheartj/ehs234
  • Gossl M, Khosla S, Zhang X, et al. Role of circulating osteogenic progenitor cells in calcific aortic stenosis. J Am Coll Cardiol. 2012;60(19):1945–1953. doi:10.1016/j.jacc.2012.07.042
  • Gossl M, Modder UI, Gulati R, et al. Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells. Eur Heart J. 2010;31(23):2909–2914. doi:10.1093/eurheartj/ehq373
  • Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–324. doi:10.1002/art.1780310302
  • Chan YH, Ngai MC, Chen Y, et al. Cumulative rheumatic inflammation modulates the bone-vascular axis and risk of coronary calcification. J Am Heart Assoc. 2019;8(11):e011540. doi:10.1161/JAHA.118.011540
  • Peris P, Atkinson EJ, Gossl M, et al. Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. Mayo Clin Proc. 2013;88(1):46–55. doi:10.1016/j.mayocp.2012.08.019
  • Wang S, Yiu KH, Mok MY, et al. Prevalence and extent of calcification over aorta, coronary and carotid arteries in patients with rheumatoid arthritis. J Intern Med. 2009;266(5):445–452. doi:10.1111/j.1365-2796.2009.02123.x
  • Chan YH, Siu CW, Yiu KH, et al. Abnormal vascular function in PR-interval prolongation. Clin Cardiol. 2011;34(10):628–632. doi:10.1002/clc.20958
  • Chan YH, Siu CW, Yiu KH, et al. Adverse systemic arterial function in patients with selenium deficiency. J Nutr Health Aging. 2012;16(1):85–88. doi:10.1007/s12603-011-0086-5
  • Tanaka Y, Ohira T. Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system. Curr Opin Pharmacol. 2018;40:110–119. doi:10.1016/j.coph.2018.03.006
  • Poubelle PE, Chakravarti A, Fernandes MJ, Doiron K, Marceau AA. Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils. Arthritis Res Ther. 2007;9(2):R25. doi:10.1186/ar2137
  • Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther. 2007;9(Suppl 1):S1. doi:10.1186/ar2165
  • Flammer AJ, Gossl M, Li J, et al. Patients with an HbA1c in the prediabetic and diabetic range have higher numbers of circulating cells with osteogenic and endothelial progenitor cell markers. J Clin Endocrinol Metab. 2012;97(12):4761–4768. doi:10.1210/jc.2012-2642
  • Bostrom KI, Rajamannan NM, Towler DA. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res. 2011;109(5):564–577. doi:10.1161/CIRCRESAHA.110.234278